对皮塔瓦斯塔丁与SLCO1B1遗传多态性相关的生理学基础的药理动力学 (PBPK) 建模
Chang-Keun Cho1, Ju Yeon Mo1, Eunvin Ko1
1School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
Archives of pharmacal research
|December 30, 2023
概括
这项研究开发了一种基于生理学的药理动力学 (PBPK) 模型,以根据SLCO1B1遗传变异预测皮塔瓦斯塔丁药物水平. 该模型准确地预测了皮塔瓦斯塔丁的药理动力学,有助于针对高胆固醇血症的个性化剂量策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
- 计算生物学 计算生物学
背景情况:
- 皮塔瓦斯塔丁是一种用于高胆固醇血症的他类药物,其肝脏吸收受到OATP1B1载体的影响.
- SLCO1B1基因编码OATP1B1,其遗传变异 (多态) 显著影响皮塔瓦斯塔丁的药理学特征.
- 了解这些遗传影响对于优化皮塔瓦斯塔丁治疗至关重要.
研究的目的:
- 开发和验证皮塔瓦斯塔丁的生理学基础药理动力学 (PBPK) 模型.
- 为了预测不同SLCO1B1遗传变异 (双型) 的皮塔瓦斯塔丁药理动力学.
- 为了提供一个工具来个性化皮塔瓦斯塔丁剂量策略.
主要方法:
- 利用PK-Sim®软件构建了皮塔瓦斯塔丁的全身PBPK模型.
- 集成的药物基因组数据和27个临床药物动力学数据集用于模型开发和验证.
- 优化了皮塔瓦斯塔丁的物理化学和处置特性,以匹配观察到的血度-时间概况.
主要成果:
- 已建立的PBPK模型准确地预测了各种SLCO1B1双型的皮塔瓦斯塔丁血度-时间概况.
- 预测的药理动力学参数 (AUC,Cmax) 在观察值的两倍误差范围内.
- 该模型与基因型和非基因型种群的观察数据有很好的一致性.
结论:
- 一个强大的PBPK模型成功地建立了皮塔瓦斯塔丁,解释了SLCO1B1遗传多态性.
- 这种模型可以准确地预测不同人群中皮塔瓦斯塔丁的药理动力学.
- 这些发现支持基于个体遗传构成和人口统计数据的个性化皮塔瓦斯塔丁剂量潜在的可能性.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
40
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
40
Pharmacokinetic Models: Comparison and Selection Criterion
74
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
74
Physiological Pharmacokinetic Models: Assumption with Protein Binding
45
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
45
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
150
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
150
Pharmacokinetic Models: Overview
703
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
703
Model Approaches for Pharmacokinetic Data: Physiological Models
47
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
47


